Progyny, Inc. Other Comprehensive Income (Loss), Net of Tax
Progyny, Inc. (PGNY) reported Other Comprehensive Income (Loss), Net of Tax of -$2.78 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-03-03
- Progyny, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-12-31 was -$291.00K, a 129.97% decline year-over-year.
- Progyny, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was -$1.70M, a 321.28% decline year-over-year.
- Progyny, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was -$725.00K, a 302.51% decline year-over-year.
- Progyny, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was -$69.00K, a 130.94% decline year-over-year.
- Progyny, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$2.78M, a 219.93% decline from fiscal 2023.
- Progyny, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $2.32M, a 290.24% increase from fiscal 2022.
- Progyny, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was $594.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.99M derived: sum of 2 quarters · filed 2025-03-03 | -$2.71M derived: sum of 3 quarters · filed 2025-03-03 | -$2.78M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$1.70M 10-Q · filed 2024-11-12 | -$2.42M derived: sum of 2 quarters · filed 2024-11-12 | -$2.49M 10-Q · filed 2024-11-12 | -$1.52M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | -$725.00K 10-Q · filed 2024-08-07 | -$794.00K 10-Q · filed 2024-08-07 | $177.00K derived: sum of 3 quarters · filed 2025-03-03 | $943.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | -$69.00K 10-Q · filed 2024-05-10 | $902.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.67M derived: sum of 3 quarters · filed 2025-03-03 | $2.03M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | $971.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.74M derived: sum of 2 quarters · filed 2025-03-03 | $2.10M derived: sum of 3 quarters · filed 2025-03-03 | $2.32M 10-K · filed 2025-03-03 |
| 2023-09-30 | $766.00K 10-Q · filed 2024-11-12 | $1.12M derived: sum of 2 quarters · filed 2024-11-12 | $1.35M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $358.00K 10-Q · filed 2024-08-07 | $581.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $223.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $594.00K 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |